Science. Simplicity. Partnership.


Roche granted FDA Breakthrough Device Designation for pTau217 blood test to support earlier Alzheimer's disease diagnosis
Alzheimer's Disease

Elecsys® pTau217 blood test receives FDA Breakthrough Device Designation

Test development is a Roche and Lilly collaboration to support earlier Alzheimer’s diagnosis.

Latest news


Forecasting the future of cancer diagnostics
Forecasting the future of cancer diagnostics

One of our experts answers questions about innovations in tissue and digital pathology.

Learn more

Roche Diagnostics Lab Week 2024
Lab Week
Roche Diagnostics celebrates Lab Week

In a world where you can be anything, be a laboratory professional.

Learn more

Tucson Symposium
Tucson Symposium

Thought leaders and cancer experts drive advancements in pathology and oncology to improve outcomes and shape the future.

Register now

Related links


Learn more about our portfolio of lab instruments, systems, assays and more  

Begin exploring


More than 800,000 documents available on demand — always up-to-date with 24/7 access

Log in to eLabDoc


Empowering learning — e-learning content, PACE/CEU courses, and more

Start training